Novartis: all 3,900 studies
Page 36 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood PressureCompletedNCT00260923Phase 3
- A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 DiabetesCompletedNCT00260156Phase 3
- A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart FailureCompletedNCT00259116Phase 2
- Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of LaborCompletedNCT00259103Phase 2
- Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.TerminatedNCT00258765Phase 2
- Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14CompletedNCT00254878Phase 3
- A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and HypercholesterolemiaCompletedNCT00254475Phase 3
- GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast CancerTerminatedNCT00251433Phase 1
- A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant SchizophreniaCompletedNCT00250575Phase 3
- A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.CompletedNCT00250562Phase 3
- Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyTerminatedNCT00248157Phase 3
- A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes LabialisCompletedNCT00248144Phase 4
- Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyTerminatedNCT00248131Phase 3
- Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast CancerCompletedNCT00247663Phase 2
- Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant TherapyCompletedNCT00247650Phase 2
- A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)CompletedNCT00246584Phase 2
- TKI258 in Subjects With Refractory or Relapsed Multiple MyelomaTerminatedNCT00243763Phase 1
- Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone MetastasesCompletedNCT00242554Phase 4
- Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or MacroadenomasTerminatedNCT00242541Phase 4
- Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.WithdrawnNCT00242528Phase 4
- Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic SyndromeCompletedNCT00241150Phase 4
- A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 MgCompletedNCT00241137Phase 3
- Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With DiabetesCompletedNCT00241124Phase 4
- Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone MetastasisCompletedNCT00241111Phase 4
- The VALIDATE Study of Valsartan for Patients With Early Stage Heart FailureCompletedNCT00241098Phase 4
- Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes MellitusCompletedNCT00241085Phase 4
- Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose ToleranceCompletedNCT00241072Phase 4
- Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant RecipientsCompletedNCT00241059Phase 4
- Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk AssessmentTerminatedNCT00241046Phase 4
- Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular CarcinomaCompletedNCT00241020Phase 3
- A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With HypertensionCompletedNCT00241007Phase 3
- Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney RecipientsCompletedNCT00240955Phase 4
- Letrozole in the Treatment of Severe and Recurrent EndometriosisCompletedNCT00240942Phase 2
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239902Phase 2
- Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal WomenCompletedNCT00239889Phase 4
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239876Phase 3
- Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant RecipientsCompletedNCT00239863Phase 3
- Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239811Phase 3
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239798Phase 2
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239785Phase 3
- Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant PatientsCompletedNCT00239083Phase 4
- Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant RecipientsCompletedNCT00239070Phase 3
- Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,CompletedNCT00239057Phase 3
- An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant RecipientsCompletedNCT00239044Phase 3
- Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term SteroidsCompletedNCT00239031Phase 3
- Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant PatientsCompletedNCT00239018Phase 4
- Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.CompletedNCT00238992Phase 3
- A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)CompletedNCT00238979Phase 4
- Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate MofetilCompletedNCT00238966Phase 4
- Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant RecipientsCompletedNCT00238953Phase 4
- Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney TransplantsCompletedNCT00238940Phase 3
- Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver TransplantationCompletedNCT00238901Phase 3
- A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00238498Phase 2
- An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I DisorderCompletedNCT00238485Phase 3
- A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin ExcretionCompletedNCT00238472Phase 4
- Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant RecipientsCompletedNCT00238446Phase 3
- An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United StatesCompletedNCT00237263Phase 2
- Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose ToleranceCompletedNCT00237250Phase 3
- Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00237237Phase 3
- Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With LetrozoleCompletedNCT00237224Phase 4
- Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast CancerCompletedNCT00237211Phase 2
- Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen TreatmentCompletedNCT00237198Phase 2
- Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)CompletedNCT00237172Phase 2
- Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone MetastasisCompletedNCT00237159Phase 4
- Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone OrchiectomyCompletedNCT00237146Phase 4
- Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal WomenCompletedNCT00237133Phase 4
- Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)CompletedNCT00237120Phase 3
- Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor TreatmentCompletedNCT00234637Phase 4
- Efficacy, Safety and Tolerability of Co-artemether in Non-immune TravelersCompletedNCT00233337Phase 4
- Pimecrolimus Cream 1% in Adult Patients With Perioral DermatitisCompletedNCT00232115Phase 3
- Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaCompletedNCT00232102Phase 3
- Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With DyspepsiaCompletedNCT00232089Phase 3
- Verification Study of Ciclosporin for Atopic DermatitisCompletedNCT00232076Phase 3
- Long-term Study of Ciclosporin for Atopic DermatitisCompletedNCT00232063Phase 3
- Study of Omalizumab in Moderate to Severe Bronchial AsthmaCompletedNCT00232050Phase 3
- Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaCompletedNCT00232037Phase 3
- Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With DyspepsiaCompletedNCT00232024Phase 3
- Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic DermatitisCompletedNCT00232011Phase 3
- Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic DermatitisCompletedNCT00231998Phase 3
- Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple MyelomaCompletedNCT00231166Phase 1
- A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)CompletedNCT00230074Phase 2
- Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant RecipientsCompletedNCT00229138Phase 4
- An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.CompletedNCT00228059Phase 3
- Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft RecipientsCompletedNCT00228020Phase 3
- Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand DermatitisCompletedNCT00226707Phase 3
- Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With AcromegalyCompletedNCT00225979Phase 3
- Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.CompletedNCT00219323Phase 3
- RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With FamciclovirCompletedNCT00219310Phase 4
- Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung CancerCompletedNCT00219297Phase 2
- Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate CancerCompletedNCT00219271Phase 4
- Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple MyelomaCompletedNCT00219258Phase 3
- An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive DeficitsCompletedNCT00219245Phase 4
- An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseCompletedNCT00219232Phase 3
- Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone MetastasesCompletedNCT00219219Phase 4
- A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders PatientsCompletedNCT00219193Phase 3
- Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood PressureCompletedNCT00219180Phase 3
- A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood PressureCompletedNCT00219167Phase 3
- A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of AmlodipineCompletedNCT00219154Phase 3
- A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.CompletedNCT00219128Phase 3
- A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mgCompletedNCT00219115Phase 3